UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051220
Receipt number R000058414
Scientific Title Clarification the mechanism of the right ventricular failure related to chronic pulmonary regurgitation in adult patients with congenital heart disease
Date of disclosure of the study information 2023/06/01
Last modified on 2023/06/01 11:37:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clarification the mechanism of the right ventricular failure related to chronic pulmonary regurgitation in adult patients with congenital heart disease

Acronym

Clarification the mechanism of the right ventricular failure related to chronic pulmonary regurgitation in adult patients with congenital heart disease

Scientific Title

Clarification the mechanism of the right ventricular failure related to chronic pulmonary regurgitation in adult patients with congenital heart disease

Scientific Title:Acronym

Clarification the mechanism of the right ventricular failure related to chronic pulmonary regurgitation in adult patients with congenital heart disease

Region

Japan


Condition

Condition

Adult congenital heart disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The aim of this study is to elucidate the mechanism of right ventricular failure related to chronic pulmonary regurgitation in adult patients with congenital heart disease by single nucleus transcriptome analysis using the human right ventricular myocardial tissues which are obtained intraoperably from the patients undergoing surgical pulmonary valve replacement for chronic pulmonary regurgitation.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Identification of specific molecules associated with right ventricular failure related to chronic pulmonary regurgitation.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with adult congenital heart disease scheduled for surgical pulmonary valve replacement for significant pulmonary regurgitation.

Key exclusion criteria

1.Patients who refused to participate in the study.
2.the investigator determined that the participant was inappropriate for the study.

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Terunobu
Middle name
Last name Fukuda

Organization

Kobe University Hospital

Division name

Division of Cardiovascular Medicine

Zip code

650-0017

Address

5-2, Kusunokucho 7-chome, Chuo-ku, Kobe-shi, Hyogo

TEL

078-382-5846

Email

tefukuda@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Terunobu
Middle name
Last name Fukuda

Organization

Kobe University Hospital

Division name

Division of Cardiovascular Medicine

Zip code

650-0017

Address

5-2, Kusunokucho 7-chome, Chuo-ku, Kobe-shi, Hyogo

TEL

078-382-5846

Homepage URL


Email

tefukuda@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Secretariat of Medical Ethics Committee (Observational Research), Division of Research Ethics, Center for Clinical Research Promotion, Kobe University Hospital

Address

5-2, Kusunokucho 7-chome, Chuo, Kobe, Hyogo

Tel

0783825111

Email

kansatsu@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸大学医学部附属病院 (兵庫県)、兵庫県立こども病院 (兵庫県)、加古川中央市民病院 (兵庫県)


Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2023 Year 07 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2023 Year 06 Month 01 Day

Last modified on

2023 Year 06 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058414


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name